AI
AC Immune Ltd
🇺🇸XNAS.ACIUUnited StatesHealthcare
$2.70USDup +0.02 (+0.75%)OpenDelayed5:05 PM
Price$2.70+0.02 (+0.75%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- CH0329023102
- CUSIP
- H00263105
Company
- Employees
- 90
- Headquarters
- Lausanne, United States
- Website
- https://www.acimmune.com
- CEO
- Dr. Martin Zugel M.D., Ph.D.
Market
- Shares outstanding
- 99.4M
- Market cap
- $268.45M
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $264.48M
- EPS LTM
- -CHFÂ 0.43calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- CHFÂ 17.51M-39.45%down year on year
- Net income
- -CHFÂ 43.16M+14.56%up year on year
- Gross margin
- 100%+100.32%up year on year
- Free cash flow
- -CHFÂ 34.95M+19.86%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.